Active ingredient
- levodopa
- benserazide hydrochloride
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00031/0227.
Madopar CR 100 mg/25 mg Prolonged Release Hard Capsules
Package leaflet: Information for the patient
Madopar CR 100 mg/25 mg Prolonged Release Hard Capsules
levodopa and benserazide (as hydrochloride)
Please read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet
1. What Madopar CR is and what it is used for
2. What you need to know before you take Madopar CR
3. How to take Madopar CR
4. Possible side effects
5. How to store Madopar CR
6. Contents of the pack and other information
1. What Madopar CR is and what it is used for
Madopar CR capsules contain two medicines called levodopa and benserazide. They are used to treat Parkinson’s disease.
People with Parkinson’s disease do not have enough dopamine in certain parts of their brains. This can result in slow movements, stiff muscles and tremor.
Madopar CR works like this:
The capsules are designed to release the medicines into your body slowly. This is why they are called ‘CR’ which stands for ‘controlled release’.
2. What you need to know before you take Madopar CR
Do not take Madopar CR if:
Do not take Madopar CR if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before you take Madopar CR.
Warnings and precautions
Talk to your doctor or pharmacist before taking Madopar CR if:
Tell your doctor if you or your family/carer notices you are developing urges or cravings to behave in ways that are unusual for you or you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These behaviours are called impulse control disorders and can include addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to review your treatments.
If any of the above apply to you, or if you are not sure, talk to your doctor or pharmacist before you take Madopar CR.
Other medicines and Madopar CR
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Madopar CR can affect the way some medicines work. Also some other medicines can affect the way Madopar CR works.
Do not take Madopar CR if you have taken a medicine for depression called a ‘non-selective monoamine oxidase inhibitor’ (MAOI) in the last 14 days. These medicines include isocarboxazid and phenelzine. If this applies to you, do not take Madopar CR and ask your doctor or pharmacist for advice.
In particular, tell your doctor or pharmacist if you are taking the following medicines:
Operations
If you are going to have an operation, tell the doctor that you are taking Madopar CR. This is because you may need to stop taking it before you have a general anaesthetic.
Tests
If you need to have tests on your blood or urine, tell the doctor or nurse that you are taking Madopar CR. This is because the medicine may affect the results of some tests.
Pregnancy and breast-feeding
Do not take Madopar CR if you are pregnant, trying to get pregnant or breast-feeding. This is because Madopar CR may affect your baby. It is important for women to use contraception while taking the medicine.
If you get pregnant while taking Madopar CR, talk to your doctor straight away.
Driving and using machines
Talk to your doctor about driving and using machines or tools, when you take Madopar CR. This is because one of the medicines in Madopar CR, levodopa, can make you feel very sleepy. This can happen very quickly, even during the day. You must not drive or use machines if this happens to you. If you are in any doubt about whether you can do a particular activity, talk to your doctor.
Madopar CR contains soya oil
If you are allergic to peanut or soya, do not use this medicinal product. (Refer to Section 6: Contents of the pack and other information.)
3. How to take Madopar CR
Always take Madopar CR exactly as your doctor has told you. You should check with your doctor if you are not sure. How much you take and when you take it is different for different people.
Patients NOT already treated with levodopa:
Patients already treated with levodopa:
If you forget to take Madopar CR
If you stop taking Madopar CR
You must not stop taking your capsules without talking to your doctor first. This is because if you stop taking the capsules suddenly it can cause something called ‘neuroleptic malignant-like syndrome’ (NMLS). Early signs include increased shaking, sudden high body temperature and muscle problems including stiffness and trouble with balance and keeping upright (postural instability) especially if seen with sweating, paleness and fast heart beat. NMLS can be life threatening.
If the above apply to you, talk to a doctor or go to a hospital straight away.
If you take more Madopar CR than you should
If you take more Madopar CR than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you. The following effects may happen if you have taken more capsules than you should: changes in your heart beat, confusion, difficulty sleeping, feeling or being sick and unusual movements of different parts of the body that you cannot control.
If someone else takes your Madopar CR capsules by mistake, they should talk to a doctor or go to a hospital straight away.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines Madopar CR can cause side effects, although not everyone will get them.
See your doctor as soon as possible if you get the following side effects:
Other possible side effects:
Not known (frequency cannot be estimated from the available data)
Stomach and gut:
Heart and circulation:
Blood:
Mental problems:
Impulse Control Disorders:
You may experience an inability to resist the impulse to perform an action that could be harmful, which may include:
Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or reducing the symptoms
Others:
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
5. How to store Madopar CR
6. Contents of the pack and other information
What Madopar CR contains
There are two active substances in Madopar CR 100 mg/25 mg Prolonged Release Hard Capsules. Each capsule contains 100 mg levodopa and 25 mg benserazide as the hydrochloride.
Other ingredients in the capsules are hypromellose (E464), hydrogenated vegetable oil (from refined, hydrogenated soya-bean oil and castor wax), calcium hydrogen phosphate anhydrous (E341), mannitol (E421), talc (E533b), povidone (E1201), magnesium stearate (E572), gelatin, indigo carmine (E132), titanium dioxide (E171), yellow iron oxide (E172) and red iron oxide (E172).
What Madopar CR looks like and contents of the pack
The capsules are green and blue in colour and have Roche printed on each end.
Madopar CR is supplied in amber coloured glass bottles containing 100 capsules.
Marketing Authorisation Holder
Manufacturer (Great Britain)
Manufacturer (Northern Ireland)
This leaflet was last revised in January 2022
uk-pil-madopar-clean-220103-125-cr-caps-0227
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
+44 (0)1707 366 000
+44 (0)800 328 1629
+44 (0)800 731 5711
+44 (0)1707 338 297
+44 (0)1707 384555